New
HealthMore in Health→
NHS-Galleri Trial Publishes Secondary Analyses of Multi-Cancer Blood Test
Key Takeaways
- Nature Medicine published secondary endpoint analyses from the NHS-Galleri randomized controlled trial on 22 September 2026.
- The trial evaluates a multi-cancer early detection blood test within England's National Health Service.
- Secondary endpoints explore subgroup performance, downstream testing and other dimensions beyond the primary outcome.
- Secondary analyses are typically hypothesis-generating and should be read alongside primary results.
DE
DT Editorial Team··via nature.com